Untitled Document
www.expresshealthcare.in INSIGHT INTO THE BUSINESS OF HEALTHCARE
November 2008  
Untitled Document
Sections

Market
Wellness & Preventive Care
Edge
Delhi-NCR
IT@Healthcare
Strategy

Services
Subscribe/Renew
Archives/Search
Contact Us
Network Sites
Express Computer
CIO Decisions
Exp. Channel Business
Express Hospitality
Express TravelWorld
Express Pharma
Group Sites
ExpressIndia
Indian Express
Financial Express


Product Watch

Stat Diagnostics
Heliprobe

Since Barry Marshall described the Helicobacter pylori (Hpylori) and its role in different gastrointestinal diseases, an intense research effort has developed different diagnostic methods. The only non-invasive test method that can be clinically used as a diagnostic tool for on-going infection with H pylori and post-eradication follow-up is the 'urea breath test'. Different serological tests are available, but they cannot determine the actual status of the infection and can therefore only be used for screening tests. With the Radprobe, a cost-effective test is available, easy to use in the doctor's office.

How does Heliprobe work?

The Urea Breath Test method (UBT) is based on the fact that the bacteria H pylori produces an enzyme, urease, which catalyes the hydrolysis of the urea molecule into ammonium and carbon dioxide. H plyori requires the alkaline ammonium in order to establish an optimal local mucosal environment within the acidic environment of the stomach. The urea compound is an endogenous substance that contains one carbon atom, normally C, which can be replaced by its isotope C or C. Heliprobe uses the isotope C which has very low B-radioactive emission. The radioactive dose used for a Heliprobe test is 1 uCurie, which is significantly less than the radioactive dose given at a normal X-ray examination of the stomach, and equal to a few glasses of orange juice.

A Helicap is ingested with 50 ml of water. If an infection with H pylori is present in the stomach, the 'living' bacteria produces the enzyme 'urease' that metabolises the C-urea into ammonium and carbon dioxide containing the C-labelled atoms. The carbon dioxide will be assimilated through the mucosa into the blood stream and transported to the lungs where it is exhaled. By collecting the exhaled carbon dioxide in the BreathCard, the amount of CO2 produced in the stomach can be measured with the Heliprobe TM instrument. If the patient is not infected, no metabolisation of urea will occur and therefore no CO2 can be detected with the Heliprobe system. In this case, the unmetabolised C urea will pass along the digestive canal to be excreted in the urine. If the Heliprobe system detects CO2, this is diagnostic evidence of an ongoing infection with living H pylori. Heliprobe is developed for primary diagnosis of H pylori, as well as for follow-up after eradication treatment.

Laboratory & Clinical Evaluation

To ensure equivalent results comparable with sophisticated, well-established laboratory techniques used for scientific purposes, the following comparison between Heliprobe and liquid scintillation for C detection was made. A laboratory set-up (simulating the patient) with controlled parameters was established. The result of the comparison was statistically analysed applying linear regression. The outcome of the analysis shows a regression line with high correlation between these methods. Clinical validation studies involving more than 400 patients has also been performed at the Karolinska University Hospital in Stockholm, Sweden.

CONTACT:
Stat Diagnostics Services
3rd Floor, Chandrapushpa Building
Opposite New Post Office
Hirachand Desai Marg
Ghatkopar (West)
Mumbai-86
Tel: 91-22-25112424
91-22-25157206


Ypsomed India
Clickfine

Ypsomed India Private Limited has introduced Clickfine - a universal pen needle which fits in all major injection pens (Self-Injecting devices)

Features:

Clickfine pen needles are with unique click feature. They come in a size of 6mm (31 G X1/4"). These needles fits in all major brands of insulin, growth hormone and other self-injecting devices clickfine needle triple faceting needle bevel cut and quick and easy removal of the sealing foil, patented click technology, easy to twist off after injection and strong hold thanks to 5x2 snappers makes it user friendly. These needles are single use devices. These are available in the packet of five and packet of 10 needles. These are manufactured in Switzerland by Ypsomed AG.

CONTACT:
Ypsomed India Private Limited
335, Udyog Vihar, Phase- IV
Gurgaon -122015
Tel: 91 999 99 75 1 57
Email: india_info_editor@ypsomed.com
india_editor@ypsomed.com


Nice Orchid 3000
Transport Baby Incubator

The Nice Orchid 3000 - Transport Baby Incubator is a microprocessor controlled system with air and skin modes of operation, with the following features:

  • Displays air/skin temperature simultaneously with set temperature.
  • Feather-touch operation with large digital display and comprehensive alarms.
  • Memory backup to restore set temperature and control mode automatically in the event of power failure.
  • An integral and with drawable baby tray to aid resuscitation during transport.
  • An integral humidifier.
  • Internal battery backup for four hours minimum. Operates both on AC and DC currents, with visual indication for battery power status and power sources.
  • Collapsible stainless steel stand with shock absorbers.
  • Dual thermistor temperature probes, with accuracy of +0.2°C, to minimise down time and ensure accuracy. Probe interchangeable without calibration. lA, 2D (or) 2E tank mounting facility to mount gas cylinders.
  • Unimpeded access to the patient with frontal access and a minimum of two access ports and three elbow operated ports.
  • Easy to clean and disinfect.
  • High intensity CFL Light for observation.
  • Comprehensive alarms and safety features.
  • O2 driven venturi slow suction with humidified O2.
  • Accessories include: 'A' type cylinder, pressure regulator assembly, IV stand, auxiliary tray shelf for other placing additional equipment. Flow meter, O2 cylinder, O2 failure alarm.

CONTACT:
Nice Neotech Medical Systems Private Limited
85-86, Krishna Industrial Estate
Vannagaram, Mettukuppam
Chennai 600 095
Tel: 044-24764608 Fax: 044-24762594
Email: marketing@niceneotech.com
Website: www.niceneotech.com


Robonik (India)
Prietest eXP: Automatic Biochemistry Analyser

After having established state-of-art infrastructure to manufacture medical diagnostic instruments that meets quality of international standards and yet competitively priced, Robonik introduces new model prietest eXP in biochemistry analyser range. Prietest eXP is based on embedded technology which provides extended performance. It has built in power supply with stabiliser, large size colour LCD, TFT, thermal printer, dry block incubator.

Features:

  • Operation is very easy by click of mouse or keyboard.
  • Test assignment: Easy to program, Count for number of samples, blank, QC samples, standards run. Complete reagent inventory management with tracking of expiry date. Profile creation by laboratory.
  • On line reaction graph in fixed time and kinetic tests. Prompts the user validation of test.
  • Absorbance measurement is done every second for complete duration of reaction and data is stored in memory.
  • Hyperactive enzyme assay is recalculated by automatic search of linear portion of reaction in delay or read time interval.
  • Automatic air purging between two samples minimises the cross contamination.
  • Quality Control for two different levels: 50 days data with levey- Jennings Graph. lPatient assignment with complete data of patient name, PID, sex, age, contact, name of doctor who referred helps the operator to get report generation at the end of analysis. This avoids multiple manual entry saves time and eliminates manual error in data entry. Avoids paperwork.
  • Report Generation: On normal A4 paper with complete patient demography, laboratory logo, laboratory name and address, collated sample result with edition of test results obtained through other means/ equipment.
  • Large size memory: 250 user definable tests, 25,000 test results and two level QC for 30 days cumulative.
  • The data can be imported and exported by pen drive.

CONTACT:
Robonik (India) Private Limited
Plot No A-374, TTC
MIDC Industrial Area
Mahape, Navi Mumbai - 400710
Tel: 022- 27780135 (5 lines)
Fax: 022- 27780145
Email: sales@robonikindia.com
marketing@robonikindia.com
Website: www.robonikindia.com


Schiller India
Defigard 400 Multi-Pulse Biphasic Defibrillator

Schiller India, a leading Swiss joint venture company in the field of medical diagnostics, has launched a new defibrillator called Defigard 400, India's first indigenously manufactured multi-pulse Biphasic Defibrillator. According to V Balakrishnan, Vice President, Sales, "The Indian market is shifting from monophasic to biphasic defibrillators and in keeping with our goal to offer our customers the latest technology at an affordable price, Schiller has introduced its Defigard 400 Defibrillator. The Defigard 400 Defibrillator uses Schiller's patented and highly successful, multi-pulse biphasic current. This technology is widely preferred in the advance market as it results inlower tissue damage to the patient's heart and facilitates faster recovery."

Features of Defigard 400

  • Large 6.4" colour TFT screen.
  • Suitable for adult and paediatric application.
  • Multi-pulse biowave technology for external defibrillation. Selectable from 1 to 180J.
  • Visual instructions and simple three steps operation.
  • Three channel memory.
  • 24 hours ECG. Last 11 shocks data saved.
  • Trim knob and direct function keys for print, mute and freeze.
  • Digital out for ECG data to central monitoring station
  • Integrated thermal printer with auto and manual modes (optional).

CONTACT:
Hansa Soneji
Product Specialist
Schiller Healthcare India Private Limited
DC Silk Mills Compound
Kondivitta Lane
Andheri East
Mumbai - 400 059
Tel: 022 6692 0520
Fax: 022 2826 3525
Email: hansa@schillerindia.com

 


Untitled Document

Untitled Document
© Copyright 2001: Indian Express Newspapers (Mumbai) Limited (Mumbai, India). All rights reserved throughout the world. This entire site is compiled in Mumbai by the Business Publications Division (BPD) of the Indian Express Newspapers (Mumbai) Limited. Site managed by BPD.